MIST
Milestone Pharmaceuticals Inc.
Recent 8-K filings for MIST
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 13, 2026 11:23 UTC earnings item 2.02item 9.01
Milestone Q1 2026 net loss $26.1M; CARDAMYST launch yields $0.2M revenue, 600 scripts
source · MIST on sec.gov